- $49.07m
- $167.25m
- $588.14m
- 89
- 97
- 31
- 84
2019 June 29th | 2020 June 27th | 2021 July 3rd | 2022 July 2nd | 2023 July 1st | |
---|---|---|---|---|---|
Period Length: | 52 W | 52 W | 53 W | 52 W | 52 W |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 464 | 449 | 519 | 532 | 588 |
Cost of Revenue | |||||
Gross Profit | 34.6 | 35.2 | 42 | 43.2 | 47.5 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 470 | 443 | 509 | 523 | 572 |
Operating Profit | -5.96 | 6.83 | 9.53 | 8.79 | 16.3 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | -8.74 | 4.32 | 5.91 | 3.69 | 6.3 |
Provision for Income Taxes | |||||
Net Income After Taxes | -7.98 | 4.76 | 4.34 | 3.38 | 5.16 |
Net Income Before Extraordinary Items | |||||
Net Income | -7.98 | 4.76 | 4.34 | 3.38 | 5.16 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -7.98 | 4.76 | 4.34 | 3.38 | 5.16 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.01 | 0.44 | 0.393 | 0.305 | 0.15 |